Discussion of the NETTER-2 Trial

NETCast
24/09/2024 26 min Episodio 23
Discussion of the NETTER-2 Trial

Listen "Discussion of the NETTER-2 Trial"

Descargar episodio

Episode Synopsis


Join us for Episode 23 of NETCast. Ohio State University Medical Oncology Specialist Dr. Vineeth Sukrithan interviews Dr. Simron Singh professor of medicine at the University of Toronto and co-founder of the Susan Leslie Clinic for Neuroendocrine Tumors. He is also a medical oncologist and affiliate scientist in the Odette Cancer Research Program at Sunnybrook Research Institute. Join us as we review the NETTER-1 study and then discuss the NETTER-2 study.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

More episodes of the podcast NETCast

Current State of NETs, Successes, and Future Directions in Latin America 09/09/2025
The Intersection of Compassion and Burnout in NETs 12/08/2025
Promising Advances in NEC Research and Treatment 27/05/2025
Understanding the COMPETE Study and Its Implications 31/03/2025
Terapias para tumores neuroendocrinos en México 25/02/2025
2024 Symposium Abstracts: The Promise of PRRT in Neuroendocrine Tumor Treatment - Recorded November 22nd, 2024 14/01/2025
2024 Symposium Abstracts: New Research Using Biomarkers for Neuroendocrine Tumor Treatment - Recorded November 21st, 2024 07/01/2025
2024 Symposium Abstracts: Innovative Therapies for Neuroendocrine Tumors - Recorded November 20th, 2024 31/12/2024
2024 Symposium: Bridging the Gap with Patient Advocacy Groups - Recorded November 23rd, 2024 11/12/2024
American Joint Committee on Cancer (AJCC) The Future of Neuroendocrine Tumor Management 27/11/2024
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA